trial

Clozapine Use Pattern in the Province of Seville

NCTId NCT05083377
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 600 (actual)
Sponsored by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Primary completion 2021-09-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
600 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2020-09-08
Primary completion
2021-09-08
Eligibility
ALL

Interventions & indications

Drugs
—

Sponsors

Fundación Pública Andaluza para la gestión de la Investigación en SevillaLead Sponsor

Investigators

1
Benedicto Crespo Facorro, ProfessorPrincipal Investigator

Sites

1 total
Seville, Spain

Facts & assertions

4 sourced
Enrollment
600
Phase
NA
Primary Completion Date
2021-09-08
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
company
indication
Schizophrenia and Related Disorders
indication
Schizophrenia
indication
investigator
Benedicto Crespo Facorro, Professor
person